253 related articles for article (PubMed ID: 34229639)
21. Long-term trends of nasopharyngeal carcinoma mortality in China from 2006 to 2020 by region and sex: an age-period-cohort analysis.
Guo X; Cui J; Yuan X; Gao Z; Yu G; Wu H; Kou C
BMC Public Health; 2023 Oct; 23(1):2057. PubMed ID: 37864181
[TBL] [Abstract][Full Text] [Related]
22. Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014.
Li X; Zheng R; Li X; Shan H; Wu Q; Wang Y; Chen W
Chin J Cancer Res; 2017 Dec; 29(6):477-486. PubMed ID: 29353970
[TBL] [Abstract][Full Text] [Related]
23. Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea.
Moon EK; Oh CM; Won YJ; Lee JK; Jung KW; Cho H; Jun JK; Lim MC; Ki M
Cancer Res Treat; 2017 Apr; 49(2):526-533. PubMed ID: 27586676
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.
Han X; Wang Z; Huang D; Deng K; Wang Q; Li C; Zhu J
BMC Womens Health; 2022 Dec; 22(1):504. PubMed ID: 36476597
[TBL] [Abstract][Full Text] [Related]
25. Trends in cervical cancer mortality rates in Lithuania, 1987-2016.
Everatt R; Intaitė B
Cancer Epidemiol; 2018 Dec; 57():85-89. PubMed ID: 30347336
[TBL] [Abstract][Full Text] [Related]
26. Age-period-cohort analysis of infectious disease mortality in urban-rural China, 1990-2010.
Li Z; Wang P; Gao G; Xu C; Chen X
Int J Equity Health; 2016 Mar; 15():55. PubMed ID: 27036223
[TBL] [Abstract][Full Text] [Related]
27. Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006-2030: A Bayesian Age-Period-Cohort Modeling Study.
Yuan M; Zhao X; Wang H; Hu S; Zhao F
Cancer Epidemiol Biomarkers Prev; 2023 Jun; 32(6):825-833. PubMed ID: 36944168
[TBL] [Abstract][Full Text] [Related]
28. Trends in Incidence Rates, Mortality Rates, and Age-Period-Cohort Effects of Cervical Cancer - China, 2003-2017.
Sun K; Zheng R; Lei L; Zhang S; Zeng H; Wang S; Li L; Chen R; Han B; Peng J; Wei W; He J
China CDC Wkly; 2022 Dec; 4(48):1070-1076. PubMed ID: 36751372
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the effects of the age-period-birth cohort on cervical cancer mortality in the Brazilian Northeast.
Meira KC; Silva GWDS; Dos Santos J; Guimarães RM; de Souza DLB; Ribeiro GPC; Dantas ESO; Carvalho JBL; Jomar RT; Simões TC
PLoS One; 2020; 15(2):e0226258. PubMed ID: 32074101
[TBL] [Abstract][Full Text] [Related]
30. Disparities in the increases of cervical cancer incidence rates: observations from a city-wide population-based study.
Li K; Xu H; Wang S; Qin P; Liang B
BMC Cancer; 2022 Apr; 22(1):419. PubMed ID: 35428279
[TBL] [Abstract][Full Text] [Related]
31. The Effects of Age, Period, and Cohort on the Mortality of Cervical Cancer in Three High-Income Countries: Canada, Korea, and Italy.
Wang J; Bai Z; Gao X; Zhang N; Wang Z
Biomed Res Int; 2021; 2021():8829122. PubMed ID: 33490279
[TBL] [Abstract][Full Text] [Related]
32. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.
Levi F; La Vecchia C; Randimbison L; Te VC
Ann Oncol; 1994 Oct; 5(8):747-52. PubMed ID: 7826908
[TBL] [Abstract][Full Text] [Related]
33. [Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence].
Cao MD; Wang H; Shi JF; Bai FZ; Cao MM; Wang YT; Yan XX; Wang L; Huang Z; Ren JS; Zhao JJ; Dai M; Qu CF; Chen WQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1848-1858. PubMed ID: 33297650
[No Abstract] [Full Text] [Related]
34. Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?
Nowakowski A; Wojciechowska U; Wieszczy P; Cybulski M; Kamiński MF; Didkowska J
Eur J Epidemiol; 2017 Jun; 32(6):529-532. PubMed ID: 28780640
[TBL] [Abstract][Full Text] [Related]
35. Temporal Trends in Notification and Mortality of Tuberculosis in China, 2004-2019: A Joinpoint and Age-Period-Cohort Analysis.
Wang L; Wang W
Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073943
[TBL] [Abstract][Full Text] [Related]
36. [Incidence and mortality of cervical cancer in China, 2014].
Gu XY; Zheng RS; Sun KX; Zhang SW; Zeng HM; Zou XN; Chen WQ; He J
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):241-246. PubMed ID: 29730908
[No Abstract] [Full Text] [Related]
37. [Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003 - 2007].
Wei KR; Chen WQ; Zhang SW; Zheng RS; Wang YN; Liang ZH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):445-51. PubMed ID: 22932112
[TBL] [Abstract][Full Text] [Related]
38. Temporal trends in incidence and mortality of cervical cancer in China from 1990 to 2019 and predictions for 2034.
Li S; Huang M; Zhu Y; Zeng H; Zhang F
Eur J Cancer Prev; 2024 May; 33(3):252-261. PubMed ID: 37997908
[TBL] [Abstract][Full Text] [Related]
39. [Common Malignant Tumors in the Reproductive System of Chinese Women: Disease Burden During 1990-2019 and Prediction of Future Trend].
Zheng N; Tang J; Ren XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):25-32. PubMed ID: 38433627
[TBL] [Abstract][Full Text] [Related]
40. Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.
Huang Z; Zheng Y; Wen W; Wu C; Bao P; Wang C; Zhong W; Gao YT; Jin F; Xiang YB; Shu XO; Beeghly-Fadiel A
Eur J Cancer; 2016 Aug; 63():1-10. PubMed ID: 27254837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
